PER
Click for more information
6.90% 8.1¢ percheron therapeutics limited

Chart, page-1269

  1. samfiodiving
    4,099 Posts.
    lightbulb Created with Sketch. 1846
    clock Created with Sketch.
    20/01/20
    16:59
    Post #: 42477403
    Taken from the last Ann

    All participants completing the Treatment Period of the study will be offered to the enter an open label extension
    study of ATL1102 conducted under a separate protocol and will be given the highest dose tested in the study or
    the highest dose considered generally safe and well tolerated in the study. This will serve to further increase the
    safety and efficacy database.
    ANP Price at posting: 7.4¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
TLG Talga to form joint venture with lithium producer SQM to develop Sweden's Aero project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢ 		Change
-0.006(6.90%) 		Mkt cap ! $73.02M
Open High Low Value Volume
8.7¢ 8.7¢ 8.1¢ $154.2K 1.820M

Buyers (Bids)

No. Vol. Price($)
2 33824 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 275242 2
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.